Cargando…
Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental Mycobacterium avium infection in mice
BACKGROUND & OBJECTIVES: Mycobacterium avium causes atypical infection in both immunocompetent and immunocompromised individuals. Conventional chemotherapy for M. avium infection is not efficient due to lengthy course of treatment and drug-associated toxic side effects. The present study was aim...
Autores principales: | Grewal, Tapinder Kaur, Majeed, Shahnawaz, Sharma, Sadhna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118139/ https://www.ncbi.nlm.nih.gov/pubmed/30168492 http://dx.doi.org/10.4103/ijmr.IJMR_2004_15 |
Ejemplares similares
-
Effect of nanoencapsulation on the phenomenon of drug interaction between anti-M.avium drug, rifabutin and anti-HIV drug, ritonavir by employing poly (lactide-co-glycolide) nanoparticles
por: Grewal, Tapinder, et al.
Publicado: (2012) -
Therapeutic implications of nanoencapsulated M. avium / HIV drugs against experimental tuberculosis in mice
por: Grewal, Tapinder, et al.
Publicado: (2012) -
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019) -
Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in Mycobacterium avium Complex Lung Disease
por: Kwon, Yong Shik, et al.
Publicado: (2020) -
Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021)